Home » Astellas and Item File Lawsuit Against Adenoscan Generic
Astellas and Item File Lawsuit Against Adenoscan Generic
Astellas US LLC and Astellas Pharma US Inc. along with ITEM Development AB announced that they have filed a patent infringement lawsuit in the United States against Sicor, Sicor Pharmaceuticals, Teva Pharmaceuticals USA, and Teva Pharmaceutical Industries (collectively, "Sicor") regarding submission of an abbreviated new drug application for a generic version of Adenoscan (adenosine injection), a pharmacologic stress agent indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.
()a href="http://www.mysan.de/article115104.html" target="_blank">mysan.de
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May